Abstract
Localization of basic fibroblast growth factor (bFGF) in a metastatic cell line, AT-3, established from the Dunning prostatic carcinoma of rat was determined by two immunological techniques using a specific monoclonal antibody against bFGF. Concentration of bFGF in cell extract was measured by sandwich radioimmunoassay (RIA) with heparin-Sepharose and 125I-labeled monoclonal antibody. bFGF concentration in the extract of AT-3 cells increased with increasing concentration of NaCl in extraction buffer. Localization of bFGF in AT-3 cells was determined by counting radioactivity of 125I-labeled monoclonal antibody binding to AT-3 cells before or after increasing permeability of the cells. The binding increased significantly by this treatment, indicating that bFGF within the cells was detected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- FGF:
-
fibroblast growth factor
- bFGF:
-
basic fibroblast growth factor
- aFGF:
-
acidic fibrolast growth factor
- CHAPS:
-
3-[(3-chol-amidopropyl) dimenthylammonio]-1-propane sulfonate:
- PBS:
-
phosphate buffered saline
- BSA:
-
bovine serum albumin
References
Burgess W.H. and Maciag T., The heparin-binding (fibroblast) growth factor family of proteins, Annu. Rev. Biochem. 58:575–606 (1989).
Rifkin D.B. and Moscatelli D., Recent development in the cell biology of basic fibroblast growth factor. J.Cell Biol. 109:1–6 (1989).
Lobb R., Sasse J., Sullivan R., Shing Y., D’Amore P., Jacobs J. and Klagsbrun M., Purification and characterization of heparin-binding endothelial cell growth factors, J. Biol. Chent. 261:1924–1928 (1986).
Yoshitake Y. and Nishikawa K., Submitted for publication.
Folkman J. and Klagsbrun M., Angiogenesis factors, Science 235:442–447 (1987).
Schweigerer L., Neufeld G., Mergia A., Abraham J.A., Fiddes J.C. and Gospodarowicz D., Proc. Natl. Acad. Sci. USA 84:842–846 (1987).
Isaacs J.T., Isaacs W.B., Feitz W.P.J. and Scheres J., Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers, The Prostate 9:261–281 (1986).
Matuo Y., Nishi N., Tanaka H., Sasaki I., Isaacs J.T. and Wada P., Production of IGF-II-related peptide by an anaplastic cell line (AT-3) established from the Dunning prostatic carcinoma of rats, In Vitro Cell Dev. Biol. 24:1053–1056 (1988).
Matuo Y., Nishi N., Takasuka H., Masuda Y., Nishikawa K., Isaacs J.T., Adams P.S., McKeehan W.L. and Sato G.H., Production and significance of TGF-β in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma, Biochem. Biophys. Pes. Corun. 166:840–847 (1990).
Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H. and Nishikawa K., Monoclonal antibodies against heparin binding growth factor II (HBGF-II)/basic fibroblast growth factor (bFGF) that block its biological activity: Invalidity of the antibodies for tumor angiogenesis, Proc. Natl. Acad. Sci. USA 86:9911–9915 (1989).
Yoshitake Y. and Nishikawa K., Derivation of monoclonal antibody to basic fibroblast growth factor and its application, Methods Bnzymol. 198:148–157 (1991).
Masuda Y., Yoshitake Y. and Nishikawa K., Growth control of A431 cells in protein-free medium: Secretory products do not affect cell growth, In Vitro Cell. Dev. Biol. 24:893–899 (1988).
Yoshitake Y., Nishikawa K. and Adachi K., DNA synthesis-stimulating activities for BALB/3T3 cells present in histone and nonhistone protein fractions from rat Rhodamine fibrosarcoma, Cell Struct. Punc. 7:229–243 (1982).
Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J. and Klagsbrun M., Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor, Science 223:1296–1299 (1984).
Matsuzaki K., Yoshitake Y., Miyagiwa M., Minemura M, Tanaka M., Sasaki H. and Nishikawa K., Production of basic fibroblast growth factor-like factor by cultured human cholangiocellular carcinoma cells, Jpn. J. Cancer Res. 81:345–354 (1990).
Yoshitake Y. and Nishikawa K., Production of monoclonal antibodies with specificity for different epitopes on the epidermal growth factor molecule, Arch. Biochem. Biophys. 263:437–446 (1988).
Klagsbrun K. and Shing Y., Heparin affinity of anionic and cationic endothelial cell growth factors: Analysis of hypothalamus-derived growth factors and fibroblast growth factors, Proc. Natl. Acad. Sci. USA 82:805–809 (1985).
Masuda Y., Yoshitake Y. and Nishikawa, Secretion of DNA synthesis factor (DSF) by A431 cells that can grow in protein-free medium, Cell Biol. Int. Pep. 11:359–365 (1987).
Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J. and Klagsbrun M., Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix, Proc. Natl. Acad. Sci. USA 84:2292–2296 (1987).
Baird A. and Ling N., Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: Implications for a role of heparinase-like enzymes in the neovascular response, Biochem. Biophys. Res. Commun. 142:428–435 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nishikawa, K., Yoshitake, Y., Minemura, M., Yamada, K., Matuo, Y. (1992). Localization of Basic Fibroblast Growth Factor (bFGF) in a Metastatic Cell Line (AT-3) Established from the Dunning Prostatic Carcinoma of Rat: Application of a Specific Monoclonal Antibody. In: Karr, J.P., Yamanaka, H. (eds) Prostate Cancer and Bone Metastasis. Advances in Experimental Medicine and Biology, vol 324. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3398-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3398-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6501-3
Online ISBN: 978-1-4615-3398-6
eBook Packages: Springer Book Archive